List oral factor b inhibitor drug brands that are recognized for their pricing strategies in united states?

Short answer: There are no FDA-approved oral Factor B inhibitors in the United States, so there are no brand-name products (and thus no US pricing-strategy branding to list).

If you’d like, I can expand with:
- A quick overview of Factor B inhibitors that are in development (no approved brand names yet), including who’s developing them and their trial status.
- A look at pricing and payer considerations for complement-pathway drugs more generally (cost drivers, access programs, etc.).

Would you like me to focus on development-stage candidates (e.g., names like BCX9930, iptacopan, etc.) or on the broader pricing landscape for complement inhibitors?